Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Medipharm Labs Corp (MEDIF)

Medipharm Labs Corp (MEDIF)
0.0609 -0.0001 (-0.16%) 09:33 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
News & Headlines for Mon, Apr 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs to Sell its Hope Facility to Rubicon Organics for $4.5M

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF)...

ROMJ.VN : 0.500 (-5.66%)
MEDIF : 0.0609 (-0.16%)
ROMJF : 0.3778 (+8.07%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is proud to...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Reports Third Quarter Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company"), a specialized, research-driven company focused on...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Reports First Quarter Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Provides Conference Call Recording Details

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Reports Fourth Quarter and Full Year Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)
MediPharm Labs Provides Update on German Cannabis Legalization

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0609 (-0.16%)
LABS.TO : 0.0900 (unch)

Barchart Exclusives

Nvidia Drops 19% YTD: Is NVDA Stock Cheap Enough to Buy?
While Nvidia faces headwinds, its recent stock pullback has also lowered its valuation. Despite uncertainties, the company is still well-positioned for long-term growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective